TY - JOUR
T1 - STABILITY OF DOXORUBICIN, DAUNORUBICIN and EPIRUBICIN IN PLASTIC SYRINGES and MINIBAGS
AU - Wood, M. J.
AU - Irwin, W. J.
AU - Scott, D. K.
PY - 1990
Y1 - 1990
N2 - The shelf lives of doxorubicin, daunorubicin and epirubicin in infusion fluids were studied using high‐performance liquid chromatographic (HPLC) methods. Doxorubicin and epirubicin were stable (loss in potency of less than 10%) for 24 and 20 days respectively, when dissolved in sodium chloride solution (0–9%; pH, 6–47) at 25oC and stored in polyvinyl chloride (PVC) minibags, while daunorubicin was stable for at least 43 days. All three drugs were stable for at least 43 days in sodium chloride (0–9%; pH 6–47 and 5–20) and dextrose (5%; pH 4–36) at 4 and ‐20°C. Repeated thawing and re‐freezing of these solutions at ambient temperature did not cause degradation. All three drugs were stable for at least 43 days when reconstituted with Water‐for‐Injections BP and stored in polypropylene syringes at4°C.
AB - The shelf lives of doxorubicin, daunorubicin and epirubicin in infusion fluids were studied using high‐performance liquid chromatographic (HPLC) methods. Doxorubicin and epirubicin were stable (loss in potency of less than 10%) for 24 and 20 days respectively, when dissolved in sodium chloride solution (0–9%; pH, 6–47) at 25oC and stored in polyvinyl chloride (PVC) minibags, while daunorubicin was stable for at least 43 days. All three drugs were stable for at least 43 days in sodium chloride (0–9%; pH 6–47 and 5–20) and dextrose (5%; pH 4–36) at 4 and ‐20°C. Repeated thawing and re‐freezing of these solutions at ambient temperature did not cause degradation. All three drugs were stable for at least 43 days when reconstituted with Water‐for‐Injections BP and stored in polypropylene syringes at4°C.
UR - http://www.scopus.com/inward/record.url?scp=0024993095&partnerID=8YFLogxK
UR - https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2710.1990.tb00386.x
U2 - 10.1111/j.1365-2710.1990.tb00386.x
DO - 10.1111/j.1365-2710.1990.tb00386.x
M3 - Article
C2 - 2229207
AN - SCOPUS:0024993095
SN - 0269-4727
VL - 15
SP - 279
EP - 289
JO - Journal of Clinical Pharmacy and Therapeutics
JF - Journal of Clinical Pharmacy and Therapeutics
IS - 4
ER -